PD2 Phenotypic Drug Discovery Trademark Details

Pd2 Phenotypic Drug Discovery was registered on Tuesday, February 21, 2012 and is currently owned by Eli Lilly and Company under the registration number 4102517 . This mark is alive with a status of Registered. The last case file activity for this mark occured 12 years ago on Tuesday, February 21, 2012, according to the United State Patent & Trademark Office
Word Mark Pd2 Phenotypic Drug Discovery
Status Alive Registered 700 — Registered

Current Owner

Eli Lilly and Company of Indianapolis, IN

View all trademarks for Eli Lilly and Company
Other Trademarks for Eli Lilly and Company
Serial Number 85386817
Registration Number 4102517
Status Date Tuesday, February 21, 2012
Filing Date Tuesday, February 21, 2012
Registration Date Tuesday, February 21, 2012
Attorney Bruce W. Longbottom

Correspondent

BRUCE W. LONGBOTTOM
LILLY CORPORATE CENTER
INDIANAPOLIS, IN 46285-0001

Case File Statements

Indication of Colors Color is not claimed as a feature of the mark.
Disclaimer with Predetermined Text "Phenotypic Drug Discovery"
Description of Mark The mark consists of "PD2" where the "2" is a superscript together with the words "Phenotypic Drug Discovery".
Goods & Services Providing pharmaceutical research and development services

Classifications

International Class Codes
042 — Class 42 includes mainly services provided by persons, individually or collectively, in relation to the theoretical and practical aspects of complex fields of activities; such services are provided by members of professions such as chemists, physicists, engineers, computer programmers, etc.
U.S. Class Codes 100, 101
Status 6 — Active
Status Date Friday, August 5, 2011
First Use Anywhere Sunday, July 31, 2011
First Use In Commerce Sunday, July 31, 2011
Primary Code 042

You must be signed in to print.

Once signed in, look for the PDF button.